Trius investigator site 169 is a clinical research site located in Smyrna, Tennessee, United States 37167.
Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.
Trius investigator site 169 has participated in 1 clinical trials.
Therapeutic areas: Skin and Subcutaneous Tissue Bacterial Infections.
Sponsors: Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Tennessee · View every site in Smyrna
Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Trius investigator site 169 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Trius investigator site 169 has 1 clinical trials on record. Their work covers Skin and Subcutaneous Tissue Bacterial Infections.
Trius investigator site 169 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.